GNW-Adhoc: New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023 ()

GNW-Adhoc: New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023 () | aktiencheck.de

Related Keywords

United States ,Switzerland ,Allschwil ,Switzerland General ,American ,George Bakris ,Markus Schlaich ,Idorsia Ltd ,American Society ,Heart Association ,Kidney Week ,Late Breaking Science ,Scientific Sessions ,Des Tages ,Aktien ,örse ,Ktiencheck ,Ktienkultur ,Ktienanalysen ,Ktienempfehlungen ,Nalysen ,örsennachrichten ,Nalysten ,Research ,Eldanlage ,Investment ,örsenkurse ,Nurse ,Charts ,Intraday ,Arktberichte ,Ewsletter ,Ecdax ,Dax ,Tax ,Ebenwerte ,Dhoc ,örseninformationen ,örsenbriefe ,örsenbrief ,Ertpapiere ,Mpfehlungen ,Warrants ,Bonds ,Ptionsscheine ,S Rechner ,S Vergleich ,Nut ,Wall ,Ptionsscheinecheck ,Euemissionen ,Ertifikate ,Ohstoffe ,Nleihen ,Evisen ,